Status:

COMPLETED

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Collaborating Sponsors:

Biotronik AG

University of Bern

Conditions:

Coronary Artery Disease

Angina Pectoris

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Coronary artery stents have improved the safety and efficacy of percutaneous coronary intervention for coronary artery disease. Drug-eluting stents have been shown to decrease neointimal hyperplasia a...

Detailed Description

Background Coronary artery stents have improved the safety and efficacy of percutaneous coronary interventions compared with balloon angioplasty alone (New Engl J Med 1994; 331:489-495). Notwithstand...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age ≥18 years
  • Symptomatic coronary artery disease including patients with chronic stable angina, silent ischemia, and acute coronary syndromes including NSTE-ACS and STE-ACS
  • Presence of one or more coronary artery stenoses \>50% in a native coronary artery or a saphenous bypass graft which can be treated with a stent ranging in diameter from 2.25 to 4.0 mm and can be covered with one or multiple stents
  • No limitation on the number of treated lesions, and vessels, and lesion length
  • Exclusion Criteria
  • Pregnancy
  • Known intolerance to aspirin, clopidogrel, heparin, stainless steel, Sirolimus, Everolimus or contrast material
  • Inability to provide informed consent
  • Currently participating in another trial before reaching first endpoint
  • Planned surgery within 6 months of PCI unless dual antiplatelet therapy is maintained throughout the peri-surgical period

Exclusion

    Key Trial Info

    Start Date :

    February 1 2012

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2018

    Estimated Enrollment :

    2119 Patients enrolled

    Trial Details

    Trial ID

    NCT01443104

    Start Date

    February 1 2012

    End Date

    June 1 2018

    Last Update

    October 18 2018

    Active Locations (9)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (9 locations)

    1

    Kantonsspital Aarau

    Aarau, Switzerland, 5000

    2

    Universitätsklinik Basel

    Basel, Switzerland, 4031

    3

    Department of Cardiology, Bern University Hospital

    Bern, Switzerland, 3010

    4

    HFR Freiburg

    Fribourg, Switzerland, 1708